The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,819 followers.

RT @FrontImmunol: New Research: The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis: Objective T…

14 Apr 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis: Objective T…

14 Apr 2023

Reply Repost Favourite

New Research: The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis: Objective This meta-analysis aimed to evaluate the efficacy and safety of PD-1/PD-L1 inhibitors in patients with glioma.Methods … https://t.co/SIR

14 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.